G. Comella

发表

Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

R. Corvò, M. Benasso, R. Rosso, 1991, Cancer.

Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group.

V. Lorusso, G. Comella, N. Panza, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New cytotoxic and molecular-targeted therapies of head and neck tumors

F. Caponigro, F. Ionna, G. Comella, 2004, Current opinion in oncology.

Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.

G. Botti, C. Pacilio, G. Comella, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.

P. Ascierto, E. Simeone, M. Guida, 2007, European journal of cancer.

Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).

S. Barni, R. Labianca, G. Luporini, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer.

D. Amadori, M. Marangolo, V. Lorusso, 1993, European journal of cancer.

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.

R. Labianca, D. Amadori, L. Landi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.

F. Fiore, G. Comella, A. Daponte, 1997, Seminars in oncology.

Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma

L. Mariani, S. Palazzo, G. Comella, 2007, Oncology.

Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non‐small cell lung cancer

G. Comella, C. Anania, A. Daponte, 1994, Cancer.

A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.

O. Nanni, D. Amadori, G. Gasparini, 2011, European journal of cancer.

Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: a dose-finding study.

C. Pacilio, T. Guida, G. Comella, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.

R. Thomas, G. Botti, G. D'aiuto, 2001, Seminars in oncology.

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5‐fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck

F. Caponigro, A. Avallone, G. Comella, 1999 .

Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trials.

G. Comella, N. Panza, G. Pacilio, 1999, The oncologist.

Raltitrexed/5-fluorouracil-based combination chemotherapy regimens in anticancer therapy

F. Caponigro, A. Avallone, A. Budillon, 2001, Anti-cancer drugs.

Gemcitabine versus FLEC regimen given intra-arterially to patients with unresectable pancreatic cancer: a prospective, randomized phase III trial of the Italian Society for Integrated Locoregional Therapy in Oncology.

M. Marangolo, G. Comella, G. Luppi, 2004, Journal of chemotherapy.

Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer.

M. Marangolo, G. Comella, E. Aitini, 2003, Journal of experimental & clinical cancer research : CR.

Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.

H. McLeod, F. Caponigro, A. Avallone, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).

F. Caponigro, E. Di Gennaro, A. Avallone, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A double-blind randomized study comparing intramuscular (i.m.) granisetron with i.m. granisetron plus dexamethasone in the prevention of delayed emesis induced by cisplatin

M. Maltoni, D. Amadori, G. Luporini, 1999 .

Cisplatin, Raltitrexed, Levofolinic Acid and 5-Fluorouracil in Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study

F. Caponigro, A. Avallone, G. Comella, 2002, Oncology.

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.

S. Barni, G. Bolelli, M. Amichetti, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.

F. Fiore, G. Comella, A. Daponte, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I–II Study on a Gemcitabine-Cyclophosphamide-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients

P. Vallone, G. D'aiuto, G. Botti, 2002, Oncology.

Comparison of weekly cisplatin-epirubicin-paclitaxel (PET) with triweekly epirubicin-paclitaxel (ET) in locally advanced breast cancer (LABC). SICOG 9908 phase III tria.

R. Thomas, A. Russo, A. Petrillo, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly cisplatin-epirubicin-paclitaxel (PET) vs. triweekly epirubicin-paclitaxel (ET) in metastatic breast cancer (MBC). Interim analysis of the SICOG 9908 phase III trial.

R. Thomas, A. Russo, G. Comella, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two-month cisplatin-epirubicin-paclitaxel (PET) weekly administration for the treatment of large operable breast cancer. SICOG 0105 phase II study.

R. Thomas, M. Rinaldo, M. di Bonito, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).

R. Thomas, P. Vallone, G. Botti, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

A risk model for ovarian carcinoma patients using CA 125: Time to normalization renders second‐look laparotomy redundant

F. Zullo, G. Comella, G. Persico, 1996, Cancer.

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.

R. Labianca, D. Amadori, L. Landi, 2014 .

Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo‐leucovorin in untreated patients with advanced colorectal carcinoma

V. Gebbia, G. Comella, C. G. Stampino, 1996, Cancer.

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

G. D'aiuto, F. Caponigro, A. Budillon, 1998, Breast Cancer Research and Treatment.

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.

A. Bianco, G. Comella, N. Panza, 1996, British Journal of Cancer.

Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.

E. Biondi, G. Comella, N. Panza, 1996, Lung cancer.

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.

G. D'aiuto, L. Vizioli, M. Santangelo, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Carboplatin-Oral Etoposide Personalised Dosing in Elderly Non-small Cell Lung Cancer Patients

P. Marcatili, S. Monfardini, G. Comella, 1998 .

Phase I/II study of carboplatin and oral etoposide with granulocyte‐colony stimulating factor in advanced nonsmall cell lung cancer

G. Comella, M. Polverino, G. Persico, 1995, Cancer.

Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group Study.

V. Lorusso, G. Comella, N. Panza, 2000, Clinical lung cancer.

Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group.

F. Carpagnano, V. Lorusso, M. de Lena, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.

F. Carpagnano, C. Pacilio, V. Lorusso, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mitoxantrone plus vinorelbine with granulocyte-colony stimulating factor (G-CSF) support in advanced breast cancer patients. A dose and schedule finding study

G. Comella, F. Salzano, G. Persico, 1995, Breast Cancer Research and Treatment.

High- versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: A ‘GISCAD’ phase III study

S. Barni, R. Labianca, L. Frontini, 1997 .

Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serosal involvement.

G. Comella, G. Galizia, F. Salzano, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.

G. Peters, J. Wanders, F. Caponigro, 2002, European journal of cancer.

Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

G. D'aiuto, I. Capasso, M. Bonito, 2000, Breast Cancer Research and Treatment.

Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group

G. D'aiuto, I. Capasso, M. Bonito, 1999, Breast Cancer Research and Treatment.

Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.

P. Queirolo, B. Giannotti, A. Di Leo, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

M. Rinaldo, G. D'aiuto, A. Petrillo, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

P. Ascierto, E. Simeone, A. Cossu, 2006, BMC Cancer.

Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma).

P. Queirolo, M. Del Vecchio, N. Cascinelli, 1999, Melanoma research.

Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.

V. Lorusso, G. Comella, G. Catalano, 1996, European journal of cancer.

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma

P. Ascierto, G. Palmieri, R. Cellerino, 2000 .

Cisplatin-paclitaxel weekly schedule in advanced solid tumors: a phase I study.

G. Comella, A. Gallipoli, A. Daponte, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.

F. Caponigro, X. Pivot, A. Awada, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination Chemotherapy (CVP or Chop)-Radiotherapy Approach in Early Stage Non-Hodgkin's Lymphomas

G. Castello, G. Comella, G. Apice, 1982, Tumori.

Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG).

F. Caponigro, A. Avallone, G. Mantovani, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors

G. Melillo, G. Comella, G. Ianniello, 2004, Journal of Neuro-Oncology.

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

G. Botti, P. Ascierto, E. Simeone, 2013, Journal of Translational Medicine.

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

A. Russo, G. Comella, N. Panza, 2001, British Journal of Cancer.

Temozolomide and cisplatin in avdanced malignant melanoma.

P. Ascierto, E. Simeone, S. Scala, 2005, Anticancer research.

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

P. Vallone, G. D'aiuto, G. Botti, 2007, Cancer Chemotherapy and Pharmacology.

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

P. Vallone, G. D'aiuto, G. Botti, 2003, Cancer Chemotherapy and Pharmacology.

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.

L. Mariani, V. Gebbia, G. Comella, 1998, British Journal of Cancer.

Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study

E. Iannitto, G. Comella, F. Ferraù, 2005, Oncology.

Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies.

F. Izzo, F. Fiore, A. Avallone, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.

A. Avallone, V. Lorusso, M. de Lena, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer.

F. Caponigro, J. Bryce, A. Avallone, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination of vinorelbine, cisplatin, and etoposide in advanced non-small cell lung carcinoma: a pilot study.

G. Palmieri, G. Comella, A. Daponte, 1994, Journal of chemotherapy.

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study

R. Thomas, G. Botti, G. D'aiuto, 2006, British Journal of Cancer.

Locally Advanced Breast Cancer: Role of Chemotherapy in Improving Prognosis

G. D'aiuto, G. Comella, G. Frasci, 2008 .

Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.

V. Lorusso, M. de Lena, G. Comella, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients

P. Vallone, G. D'aiuto, G. Botti, 2005, Oncology.

Weekly Dose-Dense Cisplatin-Epirubicin-Paclitaxel Administration with Granulocyte Colony-Stimulating Factor Support Does Not Substantially Improve Prognosis in Extensive Disease Small-Cell Lung Cancer

A. Russo, G. Comella, I. Carreca, 2005, Oncology.

Estrogen Receptor-Negative and HER-2/neu-Positive Locally Advanced Breast Carcinoma: Therapy with Paclitaxel and Granulocyte-Colony Stimulating Factor

R. Thomas, G. D'aiuto, G. Comella, 2008 .

Biochemical Modulation of Fluoropyrimidines: the “Giscad” Studies

S. Barni, R. Labianca, G. Luporini, 1993 .

Gemcitabine P lus V inorelbine V ersus V inorelbine A lone i n Elderly P atients W ith A dvanced N on-Small-Cell Lung C ancer

V. Lorusso, M. Lena, G. Comella, 2000 .

Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: a dose finding study in advanced previously treated colorectal carcinoma. Southern Italy Cooperative Oncology Group.

A. Avallone, G. Comella, G. Catalano, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial.

V. Lorusso, M. de Lena, G. Comella, 2001, Lung cancer.

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site

C. Porta, V. Lorusso, G. Comella, 2006, Cancer.

Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.

P. Marcatili, S. Monfardini, G. Comella, 1998, European Journal of Cancer.

Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study.

M. Rinaldi, S. Ricci, A. Ardizzoni, 2000, American journal of clinical oncology.

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients

A. Avallone, V. Lorusso, G. Comella, 2002, British Journal of Cancer.

Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC)

A. Avallone, G. Gasparini, S. Meo, 2004 .

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer

S. Barni, R. Labianca, L. Frontini, 2001, British Journal of Cancer.

Irinotecan and Mitomycin C in 5-Fluorouracil-Refractory Colorectal Cancer Patients

A. Avallone, G. Comella, M. Biglietto, 2001, Oncology.

Immunological and clinical effects of intramuscular rIFN alpha-2a and low dose subcutaneous rIL-2 in patients with advanced malignant melanoma.

G. Castello, M. Napolitano, G. Comella, 1993, Melanoma research.

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.

C. Tibaldi, A. Ceribelli, S. Ricci, 1996, American journal of clinical oncology.

A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study.

R. Thomas, G. Botti, G. D'aiuto, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.

G. Sanguineti, V. Vitale, P. Bruzzi, 1992, The New England journal of medicine.

Is an Antiemetic Prophylactic Treatment Needed for Patients Submitted to Consecutive Days of 5-fluorouracil? An Observational Study

A. Favero, M. Maltoni, D. Amadori, 2001, Tumori.

fotemustine (FM) and dacarbazine (DTIC) versus DTIC ± interferon α in advanced malignant melanoma: A phase III study of the Southern Italy Cooperative Oncology Group (SICOG).

P. Ascierto, E. Simeone, M. G. Chiofalo, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma.

A. Cossu, G. Palmieri, A. Avallone, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly cisplatin-paclitaxel-topotecan (CPT) as front-line therapy for extensive disease small cell lung cancer (ED-SCLC). A Southern Italy Cooperative Oncology Group (SICOG) phase II study

A. Russo, G. Comella, N. Panza, 2000 .

Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI).

A. Rossi, C. Gridelli, G. Comella, 1994, Lung cancer.

High-versus low-dose levo-leucovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a 'GISCAD' phase III study. Italian Group for the Study of Digestive Tract Cancer.

S. Barni, R. Labianca, G. Luporini, 1997, Annals of Oncology.

High-dose folinic acid (FA) and fluorouracil (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer: results of a randomized multicenter clinical trial.

S. Milani, G. Comella, A. Contu, 1994, Anticancer research.

Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.

C. Gridelli, G. Comella, T. Pedicini, 1994, American journal of clinical oncology.

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma

G. Botti, P. Ascierto, E. Simeone, 2013, Journal of Translational Medicine.

Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: a phase I study of the Southern Italy Cooperative Oncology Group.

A. Avallone, G. Catalano, G. Comella, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

M. Pirovano, S. Barni, R. Labianca, 1999, British Journal of Cancer.

Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.

P. Ascierto, G. Palmieri, R. Cellerino, 2000, Cancer.

Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanoma.

F. Fiore, F. Caponigro, F. Ionna, 1997, European journal of cancer.

Gemcitabine + vinorelbine (GV) yields better survival than vinorelbine (V) alone in elderly non-small cell lung cancer (NSCLC) patients. Final analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial

V. Lorusso, M. Lena, G. Comella, 2000 .